BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38242853)

  • 1. Identification of Ligands for Ion Channels: TRPM2.
    Gu Y; Liu M; Ma L; Quinn RJ
    Chembiochem; 2024 Mar; 25(5):e202300790. PubMed ID: 38242853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancing Kir4.2 Channel Ligand Identification through Collision-Induced Affinity Selection Mass Spectrometry.
    Gu Y; Liu M; Ma L; Quinn RJ
    ACS Chem Biol; 2024 Mar; 19(3):763-773. PubMed ID: 38449446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Transient Receptor Potential Melastatin 2 (TRPM2) Channel Contributes to β-Amyloid Oligomer-Related Neurotoxicity and Memory Impairment.
    Ostapchenko VG; Chen M; Guzman MS; Xie YF; Lavine N; Fan J; Beraldo FH; Martyn AC; Belrose JC; Mori Y; MacDonald JF; Prado VF; Prado MA; Jackson MF
    J Neurosci; 2015 Nov; 35(45):15157-69. PubMed ID: 26558786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pore collapse underlies irreversible inactivation of TRPM2 cation channel currents.
    Tóth B; Csanády L
    Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13440-5. PubMed ID: 22847436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPM2: a candidate therapeutic target for treating neurological diseases.
    Belrose JC; Jackson MF
    Acta Pharmacol Sin; 2018 May; 39(5):722-732. PubMed ID: 29671419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collision-Induced Affinity Selection Mass Spectrometry for Identification of Ligands.
    Mak T; Rossjohn J; Littler DR; Liu M; Quinn RJ
    ACS Bio Med Chem Au; 2022 Oct; 2(5):450-455. PubMed ID: 37101899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of direct and indirect effectors of the transient receptor potential melastatin 2 (TRPM2) cation channel.
    Tóth B; Csanády L
    J Biol Chem; 2010 Sep; 285(39):30091-102. PubMed ID: 20650899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glia and TRPM2 Channels in Plasticity of Central Nervous System and Alzheimer's Diseases.
    Wang J; Jackson MF; Xie YF
    Neural Plast; 2016; 2016():1680905. PubMed ID: 26942016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
    Tsutsui M; Hirase R; Miyamura S; Nagayasu K; Nakagawa T; Mori Y; Shirakawa H; Kaneko S
    J Neurosci; 2018 Sep; 38(39):8484-8495. PubMed ID: 30201769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of TRPM2 channel gating revealed by cryo-EM.
    Xia S; Wang L; Fu TM; Wu H
    FEBS J; 2019 Sep; 286(17):3333-3339. PubMed ID: 31144442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective profiling of N- and C-terminal nucleotide-binding sites in a TRPM2 channel.
    Tóth B; Iordanov I; Csanády L
    J Gen Physiol; 2020 May; 152(5):. PubMed ID: 32211872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putative chanzyme activity of TRPM2 cation channel is unrelated to pore gating.
    Tóth B; Iordanov I; Csanády L
    Proc Natl Acad Sci U S A; 2014 Nov; 111(47):16949-54. PubMed ID: 25385633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicinal chemistry perspective of TRPM2 channel inhibitors: where we are and where we might be heading?
    Zhang H; Zhao S; Yu J; Yang W; Liu Z; Zhang L
    Drug Discov Today; 2020 Dec; 25(12):2326-2334. PubMed ID: 33065292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical intracellular Ca2+ dependence of transient receptor potential melastatin 2 (TRPM2) cation channel activation.
    McHugh D; Flemming R; Xu SZ; Perraud AL; Beech DJ
    J Biol Chem; 2003 Mar; 278(13):11002-6. PubMed ID: 12529379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The crystal structure of TRPM2 MHR1/2 domain reveals a conserved Zn
    Sander S; Pick J; Gattkowski E; Fliegert R; Tidow H
    Protein Sci; 2022 Jun; 31(6):e4320. PubMed ID: 35634784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four Ca2+ ions activate TRPM2 channels by binding in deep crevices near the pore but intracellularly of the gate.
    Csanády L; Törocsik B
    J Gen Physiol; 2009 Feb; 133(2):189-203. PubMed ID: 19171771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Architecture of the TRPM2 channel and its activation mechanism by ADP-ribose and calcium.
    Huang Y; Winkler PA; Sun W; Lü W; Du J
    Nature; 2018 Oct; 562(7725):145-149. PubMed ID: 30250252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and Optimization of the Novel Transient Receptor Potential Melastatin 2 Antagonist tatM2NX.
    Cruz-Torres I; Backos DS; Herson PS
    Mol Pharmacol; 2020 Feb; 97(2):102-111. PubMed ID: 31772034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of TRPM2 by extra- and intracellular calcium.
    Starkus J; Beck A; Fleig A; Penner R
    J Gen Physiol; 2007 Oct; 130(4):427-40. PubMed ID: 17893195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C-mediated phosphorylation of transient receptor potential melastatin type 2 Thr738 counteracts the effect of cytosolic Ca
    Kashio M; Masubuchi S; Tominaga M
    J Physiol; 2022 Oct; 600(19):4287-4302. PubMed ID: 36042566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.